BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

KAI MEDICAL LABORATORY — Lobbying — Receipts Report

LD-2 disclosure · 3rd Quarter - Report

KAI MEDICAL LABORATORY

via DA VINCI GROUP

3rd Quarter (July 1 - Sep 30) · 2021Posted Oct 19, 2021Filing document ↗LDA record ↗

Income$10Kfee reported

Client

Name: KAI MEDICAL LABORATORY
Description: Clinical Laboratory
Location: Texas · United States of America

Registrant

Firm: DA VINCI GROUP
Description: Government Affairs Firm
Location: Purcellville, Virginia, United States of America

Lobbying activities

1 issue

Medical/Disease Research/Clinical Labs
Funding for Clinical Research & Diagnostics Programs
Lobbyistsmr MARK RICHARD SMITH
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.